Using somatic mutations to guide treatment decisions: Context Matters

JAMA Oncology

Volumn 1, Issue 3, 2015, Pages 275-276

  Horlings, Hugo M ^a   Shah, Sohrab P ^a,b   Huntsman, David G ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ANIMAL; DRUG RESISTANCE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOLECULARLY TARGETED THERAPY; MUTATION; NEOPLASMS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATIENT SELECTION; PERSONALIZED MEDICINE; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS;

ANIMALS; BIOMARKERS, TUMOR; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS; PATIENT SELECTION; PHENOTYPE; PRECISION MEDICINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 84965093808     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2015.35     Document Type: Short Survey

References (7)

1. Prahallad A, Sun C, Huang S, et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012;483(7387):100-103.
2. Marino-Enriquez A, Fletcher CDM. Shouldn't we care about the biology of benign tumours? Nat Rev Cancer. 2014;14(11):701-702.
3. Ramos P, Karnezis AN, Craig DW, et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet. 2014;46(5):427-429.
4. Bashashati A, Ha G, Tone A, et al. Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling. J Pathol. 2013;231(1):21-34.
5. Bernards R. Finding effective cancer therapies through loss of function genetic screens. Curr Opin Genet Dev. 2014;24:23-29.
6. McLornan DP, List A, Mufti GJ. Applying synthetic lethality for the selective targeting of cancer. N Engl J Med. 2014;371(18):1725-1735.
7. Bashashati A, Haffari G, Ding J, et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer. Genome Biol. 2012;13(12):R124.